NDC 54868-6021

NDC 54868-6021

NDC 54868-6021 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 54868-6021
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 54868-6021-0 [54868602100]

Xopenex SOLUTION, CONCENTRATE
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-04-21
Inactivation Date2019-09-24

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.